• The first exhibition of Hopstem Biotechnology at 2017 International Biomedical Innovation Summit
    As a high-tech startup company in iPSCs disease modeling and drug screening platform area, Hopstem successfully held its first exhibition at the 2017 International Biomedical Innovation Summit. Besides showcases of our HopCell? products, we have also introduced our expertise in hiPSCs/hESCs differentiation, gene editing, cell banking and engineering, as well as new directions on cardio and liver cell differentiation. Our booth attracted a lot of attendees and many of them showed great interest w
    Read All
First 1 2 End